Cosmos Health (COSM) Shares Outstanding (Diluted Average) (2013 - 2026)
Cosmos Health (COSM) recorded quarterly Shares Outstanding (Diluted Average) of $47.1 million in Q1 2026, up 55.46% on a QoQ basis from $30.3 million in Q4 2025, and up 80.84% year-over-year from $26.0 million in Q1 2025.
Cosmos Health (COSM) Shares Outstanding (Diluted Average) (2013 - 2026) Analysis & Trends
Cosmos Health has disclosed Shares Outstanding (Diluted Average) across 14 years of filings, most recently posting $47.1 million for Q1 2026.
- Quarterly Shares Outstanding (Diluted Average) rose 80.84% year-over-year to $47.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.1 million (up 80.84% YoY) and the FY2025 annual result came in at $30.3 million, up 58.19% from the prior year.
- Shares Outstanding (Diluted Average) advanced to $47.1 million in Q1 2026, from $30.3 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $47.1 million in Q1 2026 and troughed at $710221.0 in Q1 2022.
- A 5-year average of $16.5 million and a median of $16.9 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) plunged 95.28% — and 2023, when it jumped 1394.62%.
- Tracing COSM's Shares Outstanding (Diluted Average) over 5 years: stood at $1.9 million in 2022, then jumped by 520.73% to $12.0 million in 2023, then soared by 59.98% to $19.1 million in 2024, then surged by 58.19% to $30.3 million in 2025, then surged by 55.46% to $47.1 million in 2026.
- Business Quant data shows COSM's Shares Outstanding (Diluted Average) at $47.1 million in Q1 2026, $30.3 million in Q4 2025, and $28.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.00 |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 124.10 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 195.38 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 236.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 116.06 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.48 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 24.54 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 47.09 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 14.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.09 Mn |
| Dec 31, 2025 | 30.29 Mn |
| Sep 30, 2025 | 28.49 Mn |
| Jun 30, 2025 | 27.40 Mn |
| Mar 31, 2025 | 26.04 Mn |
| Dec 31, 2024 | 19.15 Mn |
| Sep 30, 2024 | 17.72 Mn |
| Jun 30, 2024 | 17.03 Mn |
| Mar 31, 2024 | 16.85 Mn |
| Dec 31, 2023 | 11.97 Mn |
| Sep 30, 2023 | 12.59 Mn |
| Jun 30, 2023 | 10.82 Mn |
| Mar 31, 2023 | 10.62 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 880,542.00 |
| Jun 30, 2022 | 781,604.00 |
| Mar 31, 2022 | 710,221.00 |
| Dec 31, 2021 | 656,933.00 |
| Sep 30, 2021 | 16.10 Mn |
| Jun 30, 2021 | 15.57 Mn |